Montelukast Aristo (Montelukast)

Montelukast blocks the cysteinyl leukotriene receptor CysLT1, preventing leukotriene D4 and related molecules from triggering inflammation, bronchoconstriction, and mucus production in the respiratory tract. This receptor antagonism reduces airway swelling and improves breathing.

The specific dose of Montelukast Aristo is determined by the prescribing healthcare professional based on the patient’s age, condition severity, and clinical response. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for Montelukast in pregnancy and lactation are limited. Healthcare providers should weigh potential benefits against possible risks and discuss any concerns with the patient. Breastfeeding mothers should consult their physician before using the medication.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Montelukast belongs to the leukotriene receptor antagonist class, offering an oral alternative to inhaled corticosteroids or long‑acting beta‑agonists. It is especially useful for patients with allergic components or those who experience exercise‑induced bronchoconstriction, but it is not a rescue bronchodilator.

Montelukast Aristo should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the tablets from moisture, direct sunlight, and excessive heat to maintain potency throughout its shelf life.

Montelukast Aristo is taken orally, usually once daily, with or without food. The tablet should be swallowed whole with water and not chewed or crushed unless otherwise directed by a healthcare professional.

Serious risks include rare allergic reactions such as rash, angioedema, or anaphylaxis, as well as neuropsychiatric events like depression, mood changes, or suicidal thoughts. Patients should seek immediate medical attention if they experience any of these symptoms.

Montelukast Aristo is contraindicated in individuals with known hypersensitivity to montelukast or any component of the formulation. It should also be used with caution in patients with severe hepatic impairment or those taking interacting medications.